Screener
Supernus Pharmaceuticals SUPN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's current ratio?
- Supernus Pharmaceuticals (SUPN) reported current ratio of 2× in Q1 2026.
- How has Supernus Pharmaceuticals's current ratio changed year-over-year?
- Supernus Pharmaceuticals's current ratio decreased by 19.8% year-over-year, from 2.4× to 2×.
- What is the long-term trend for Supernus Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 2.6× to 1.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Supernus Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude